Emerging biofabrication approaches for gastrointestinal organoids towards patient specific cancer models.
Bioengineering
Externally driven assembly
Organ on a chip
Personalized medicine
Self-assembly
Journal
Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053
Informations de publication
Date de publication:
28 04 2021
28 04 2021
Historique:
received:
11
11
2020
revised:
14
01
2021
accepted:
23
01
2021
pubmed:
13
2
2021
medline:
15
9
2021
entrez:
12
2
2021
Statut:
ppublish
Résumé
Tissue engineered organoids are simple biomodels that can emulate the structural and functional complexity of specific organs. Here, we review developments in three-dimensional (3D) artificial cell constructs to model gastrointestinal dynamics towards cancer diagnosis. We describe bottom-up approaches to fabricate close-packed cell aggregates, from the use of biochemical and physical cues to guide the self-assembly of organoids, to the use of engineering approaches, including 3D printing/additive manufacturing and external field-driven protocols. Finally, we outline the main challenges and possible risks regarding the potential translation of gastrointestinal organoids from laboratory settings to patient-specific models in clinical applications.
Identifiants
pubmed: 33577978
pii: S0304-3835(21)00047-1
doi: 10.1016/j.canlet.2021.01.023
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
116-124Subventions
Organisme : NCI NIH HHS
ID : R00 CA175292
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB029805
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA199075
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.